Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alloimmunization and transfusion refractoriness to thrombocyte substitution].

D Söhngen1, W Schneider

  • 1Medizinische Klinik und Poliklinik der Heinrich-Heine Universität Düsseldorf.

Klinische Wochenschrift
|July 22, 1991
PubMed
Summary

Preventing HLA-alloimmunization requires further policy development. Strategies like single-donor transfusions and white cell depletion may delay or avoid alloimmunization in high-risk patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Rehabilitation of patients with acid-base and fluid balance disorders with short bowel syndrome after ileostomies].

Die Rehabilitation·2015
Same author

Severe musculoskeletal pain after cyclosporin A treatment in a patient undergoing allogeneic BMT.

Oncology reports·2011
Same author

Acute acalculous cholecystitis complicating oral recontamination after allogeneic bone marrow transplantation.

Oncology reports·2011
Same author

Failure of anti-infective mouth rinses and concomitant antibiotic prophylaxis to decrease oral mucosal colonization in autologous stem cell transplantation.

Bone marrow transplantation·2005
Same author

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.

European journal of haematology·2002
Same author

[Thrombotic-thrombocytopenic purpura (Moschcowitz syndrome)].

Medizinische Klinik (Munich, Germany : 1983)·2001

Area of Science:

  • Immunology
  • Transfusion Medicine
  • Hematology

Context:

  • Human Leukocyte Antigen (HLA) alloimmunization poses a significant challenge in transfusion medicine.
  • Current strategies for prevention lack universal acceptance and standardization.
  • Identifying high-risk patients is crucial for cost-effective interventions.

Purpose:

  • To review current strategies for preventing HLA-alloimmunization.
  • To discuss the potential benefits and limitations of various prophylactic measures.
  • To provide guidance on the appropriate use of HLA-selected single-donor platelets.

Summary:

  • No definitive policy exists for avoiding HLA-alloimmunization.
  • Potential strategies include single-donor transfusions, white cell depletion, UV-radiation, and cyclosporine.

Related Experiment Videos

  • Transfusion of crossmatch-compatible HLA-selected single-donor platelets is currently recommended for alloimmunized patients refractory to random-donor platelets.

    • Impact:

    • This review aims to inform clinical practice and guide future research in HLA-alloimmunization prevention.
    • Optimizing prevention strategies can improve transfusion outcomes and reduce treatment costs.
    • Highlighting cost-effectiveness underscores the need for targeted interventions in at-risk populations.